iBio Inc. (IBIO) Fundamentals

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc.
SHARE INFORMATION
Market Cap$ 54,302,484
Shares Outstanding218,082,265
Float216,963,214
Percent Float99.49%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 2,371,000
Latest Fiscal EPS$ -0.13
Latest Fiscal Date2021-06-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions176
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months3,862,621
Institutional Holdings Percent47.7%
Institutional Sold Previous 3 Months6,150,101
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent3.6
Insider Sold Previous 3 Months61,868
Insider Shares Owned7,951,620
TRADING INFO
52 Week High$ 1.76
52 Week Low$ 0.22
52 Week High Change$ -81.69
21 Day Moving Average$ 0.2905
21 Day Extended Moving Average$ 0.292397
50 Day Moving Average$ 0.3563
50 Day Extended Moving Average$ 0.342317
200 Day Moving Average$ 0.678093
200 Day Extended Moving Average$ 0.660341
10 Day Average Volume2,156,139
20 Day Average Volume2,008,979
30 Day Average Volume2,089,934
50 Day Average Volume2,320,908
Alpha0.145751
Beta-4.6729
Standard Deviation1.070559
R20.042692
7 Day Price Change$ -0.0211
7 Day Percent Change-7.81%
21 Day Price Change$ -0.051
21 Day Percent Change-17.0%
30 Day Price Change$ -0.1185
30 Day Percent Change-32.24%
Month to Date Price Change$ -0.0436
Month to Date Percent Change-14.9%
Quarter to Date Price Change$ -0.1792
Quarter to Date Percent Change-41.85%
180 Day Price Change$ -0.4537
180 Day Percent Change-64.57%
200 Day Price Change$ -0.531
200 Day Percent Change-68.08%
Year to Date Price Change$ -0.30
Year to Date Percent Change-54.64%

iBio Inc. (IBIO) Key Ratios

PROFITABILITY
EBIT Margin-1,605.3%
EBITDA Margin-1,417.4%
Pre-Tax Profit Margin-1,777.8%
Profit Margin Count0.0%
Gross Margin20.7%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 870,000
Revenue Per Share$ 0.004
Revenue (3 Years)$ -4.10
Revenue (5 Years)$ 34.71
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity0.30
Int Coverage-12.10
Current Ratio8.10
Leverage Ratio1.40
Quick Ratio7.50
Long Term Debt To Capital0.23
VALUATION MEASURES
PE Ratio-1.90
Enterprise Value$ 23,151,524
Price to Sales62.4405
Price to Free Cash-1.50
PE High Last 5 Years-0.70
Price To Book0.60
Price To Cash Flow0.00
PE Low Last 5 Years-2.80
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.20
Invoice Turnover1.10
Assets Turnover0.00
Return Assets-21.86
Return on Equity-30.05
Return on Capital-20.62

iBio Inc. (IBIO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorCohnReznick LLP
CEOThomas F. Isett
Emplyoees75
Last AuditUQ
CIK0001420720
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address8800 HSC Parkway
Suite 1601
Bryan, TX 77807-1107
Websitehttps://www.ibioinc.com
Facsimile+1 302 356-1173
Telephone+1 302 355-0650
Emailir@ibioinc.com


Your Recent History
AMEX
IBIO
iBio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.